Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

A Supplement Containing Quercetin, Bromelain, Rye Flower Pollen, and Papain for the Reduction of Radiation-Induced Prostatitis

Trial Status: administratively complete

This phase II trial studies the effect of a supplement containing quercetin, bromelain, rye flower pollen, and papain in reducing the severity of radiation-induced prostatitis. Low dose rate (LDR) brachytherapy, more commonly known as prostate “seed implant” involves permanent implementation of tiny radioactive sources into the prostate gland. These isotopes are usually palladium-131 or iodine-125. The radiation disappears over time (decays). High dose rate (HDR) brachytherapy involves the temporary implantation of a radioactive source (usually Iridium-192) that is then removed. Both HDR and LDR brachytherapy can cause inflammation of the prostate. Giving a supplement containing quercetin, bromelain, rye flower pollen, and papain may help relieve the symptoms associated with radiation induced brachytherapy.